We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
0
0 active
Approvals
Total approvals
Agencies
Regulatory bodies
Founded
2007
No trial phase data available
No trial data available
No approval data available
- Fagron has obtained regulatory clearance for the acquisition of Vepakum in Brazil and completed the acquisition of Magilab in Hungary, expanding its global pharmaceutical compounding operations. - The Vepakum acquisition allows Fagron to enter the packaging solutions vertical through two São Paulo facilities, delivering scale benefits through joint packaging and distribution services. - Magilab strengthens Fagron's position in Hungary's hospital pharmacy compounding raw materials market, which has high compounding per capita utilization. - These strategic acquisitions support Fagron's mission to deliver personalized medicine to hospitals, pharmacies, and clinics across more than 35 countries worldwide.
